A. Vénuat

发表

Genistein resistance in human leukaemic CCRF-CEM cells: selection of a diploid cell line with reduced DNA topoisomerase II beta isoform.

A. Bernheim, A. Jacquemin-Sablon, F. Goldwasser, 1995, Biochemical pharmacology.

Integration and loss of a single ν‐Ki‐ras gene affects tumorigenic potential of human osteosarcoma cells

J. Rhim, G. Carloni, B. Azzarone, 1988, FEBS letters.

Mantle cell lymphomas: characteristics, natural history and prognostic factors of 45 cases.

S. Koscielny, J. Bosq, V. Ribrag, 1997, Leukemia & lymphoma.

Cytogenetic studies on 19 papillary thyroid carcinomas

R. Berger, A. Bernheim, B. Caillou, 1992, Genes, chromosomes & cancer.

Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line

M. Greaves, M. Greaves, C. Rosenfeld, 1977, Nature.

Stromal cells and human malignant neuroblasts derived from bone marrow metastasis may share common karyotypic abnormalities: the case of the IGR-N-91 cell line.

A. Bernheim, J. da Silva, J. Bénard, 2001, Medical and pediatric oncology.

Phenotypic and genotypic diversity of human neuroblastoma studied in three IGR cell line models derived from bone marrow metastases.

A. Bernheim, J. Bénard, B. Spengler, 1999, Cancer genetics and cytogenetics.

Cytogenetic characterization of a new human papillary thyroid carcinoma permanent cell line (GLAG-66).

R. Berger, B. Caillou, M. Schlumberger, 1993, Cancer genetics and cytogenetics.

Cytogenetic abnormalities in thyroid adenomas.

R. Berger, B. Caillou, M. Schlumberger, 1991, Cancer genetics and cytogenetics.

A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid.

R. Berger, B. Caillou, C. Parmentier, 1989, Cancer genetics and cytogenetics.

High catabolism of BrdU may explain unusual sister chromatid differentiation and replication banding patterns in cancer cells.

B. Dutrillaux, N. Lemieux, L. Massaad, 1991, Cancer genetics and cytogenetics.

Cytogenetic study of a case of synchronous bilateral seminoma.

A. Bernheim, J. Droz, M. Terrier-Lacombe, 1995, Cancer genetics and cytogenetics.

Established cell line (ICI-101) obtained from frozen human lymphoblastic leukaemia cells: morphological and immunological comparison with the patient's fresh cells.

G. Mathé, D. Belpomme, J. Doré, 1969, European journal of cancer.

Comparative cytogenetic studies of normal and leukemic lymphoblastoid cell lines during the course of their establishment.

C. Rosenfeld, A. Vénuat, M. J. Testu, 1978, Cancer research.

High frequency of plasminogen activator secretion by malignant human lymphoid cell lines of T‐cell type origin

J. Soria, C. Soria, A. Houllier, 1988 .

Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children

G. Vassal, H. Avet-Loiseau, M. Terrier-Lacombe, 1999, British Journal of Cancer.

Comparative genomic hybridization detects specific cytogenetic abnormalities in pediatric ependymomas and choroid plexus papillomas.

C. Sainte-Rose, G. Vassal, J. Grill, 2002, Cancer genetics and cytogenetics.

Additional copies of a 25 Mb chromosomal region originating from 17q23.1‐17qter are present in 90% of high‐grade neuroblastomas

D. Le Paslier, A. Bernheim, G. Danglot, 1996, Genes, chromosomes & cancer.

Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents.

E. Macintyre, V. Ribrag, P. Carde, 1997, Leukemia & lymphoma.

Morphologic and molecular cytogenetics in neuroblastoma

A. Bernheim, M. Leibovitch, H. Avet-Loiseau, 1995, Cancer.

Numerical aberrations, including trisomy 22 as the sole anomaly, are recurrent in follicular thyroid adenomas

A. Bernheim, B. Caillou, M. Schlumberger, 1993, Genes, chromosomes & cancer.

100 Cytogenetic abnormalities in thyroid tumors

R. Berger, J. Rossignol, C. Parmentier, 1989 .

Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

G. Vassal, M. Bissery, J. Morizet, 1996, British Journal of Cancer.

Establishment and characterization of a truly leukaemic cell line.

G. de Thé, G. Bornkamm, J. Doré, 1977, Haematology and blood transfusion.

Cytogenetic abnormalities in a human null cell leukemia line (REH).

C. Rosenfeld, A. Vénuat, M. J. Testu, 1981, Cancer genetics and cytogenetics.

Kinetics of the establishment of human peripheral blood cultures.

C. Jasmin, T. Q. Tuan, A. Macieira-Coelho, 1969, Journal of the National Cancer Institute.

DNA-topoisomerase I, a new target for the treatment of neuroblastoma.

G. Vassal, C. Cappelli, J. Morizet, 1997, European journal of cancer.

Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.

G. Vassal, A. Watson, J. Morizet, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase II trial of fludarabine monophosphate in patients with mantle-cell lymphomas.

J. Bosq, D. Decaudin, P. Carde, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

An effect human leukaemic cell line: Reh.

A. Durandy, G. de Thé, J. Doré, 1977, European journal of cancer.

Cyclic variations in the ruthenium red stained coat of cells from a synchronized human lymphoblastoid line.

M. Paintrand, C. Rosenfeld, A. Vénuat, 1973, Experimental cell research.

SPLENECTOMY AND KARYOTYPIC CONVERSION IN CHRONIC MYELOID LEUKÆMIA

F. Vassal, J. Misset, C. Jasmin, 1979, The Lancet.

Computer-aided analysis of chromosomal aberrations occurring in an abnormal human karyotype

A. Valleron, S. Hazout, C. Rosenfeld, 1979, Human Genetics.